Notable Labs
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series B2
LATEST DEAL TYPE
$40M
LATEST DEAL AMOUNT
30
INVESTORS
Description
Provider of drug testing services intended to help oncologists identify actionable treatment options for people with blood cancers. The company services prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor as well as involved in discovering novel uses of drugs and defining mechanisms underlying development of cancer progression and drug resistance, enabling patients to identify personalized cancer treatments options to cure their diseases.
Website
Formerly Known As
StemCycle
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
- 665 3rd Street
- Suite 535
- San Francisco, CA 94107
- United States
+1 (415) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Notable Labs’s full profile, request a free trial.
Notable Labs Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Early Stage VC (Series B2) | 16-Jul-2019 | $40M | 000.00 | 00000 | Completed | Generating Revenue |
| 7. Early Stage VC (Series A1) | 06-Sep-2017 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 6. Early Stage VC | 15-Mar-2017 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 5. Early Stage VC | 16-May-2016 | 00.000 | 00.000 | Completed | Startup | |
| 4. Early Stage VC | 01-Jun-2015 | 00000 | Completed | Startup | ||
| 3. Accelerator/Incubator | 24-Mar-2015 | 00000 | 00000 | 00.000 | Completed | Startup |
| 2. Early Stage VC | 01-Mar-2015 | Completed | Startup | |||
| 1. Early Stage VC | 01-Aug-2014 | Completed | Startup |
Notable Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 000 | |
| Series B-1 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-6 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-5 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-4 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-3 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-2 | 1,194,403 | $0.001000 | $2.62 | $2.62 | 1x | $2.62 | 4.53% | |
| Series A-1 | 3,583,743 | $0.001000 | $2.92 | $2.92 | 1x | $2.92 | 13.58% |
Notable Labs Investors (30)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| B Capital Group | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Industry Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| The Capital Group Companies | Asset Manager | Minority | 000 0000 | 000000 0 | ||
| Amplify Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| BoxGroup | Venture Capital | Minority | 000 0000 | 000000 0 |
Notable Labs Executive Team (9)
2 Former Executives
You’re viewing 5 of 9 executives. Get the full list »Notable Labs Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Jim Kim | Builders VC | Board Member | 000 0000 | |
| Matthew De Silva | Notable Labs | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Peter Quinzio | Notable Labs | Co-Founder, Chief Financial Officer & and Board Member | 000 0000 |